glp 1 agonist ppt List of GLP-1 Receptor Agonists for Diabetes & Weight Loss.pdf GLP-1 Agonist | PPTX
Description
Discover the benefits of GLP-1 medications like Wegovy and Zepbound at Austin Thyroid & Endocrinology
Diabetes mellitus is a major risk factor for both cardiovascular and chronic kidney disease (CKD) while CKD is also associated with cardiovascular morbidity
The global obesity treatment market is expanding at unprecedented speed, with sales of weight-loss medications forecast to rise dramatically over the next decade.
Common versions include tirzapetide (Mounjaro/Zepbound), semaglutide (Ozempic/Wegovy/Rybelsus) and are available orally or subcutaneously (injections)
This global initiative reframed obesity as a chronic, systemic disease rather than a mere risk factor
Secondary outcomes were each of these events considered separately
